1. Home
  2. EVLV vs BCYC Comparison

EVLV vs BCYC Comparison

Compare EVLV & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVLV
  • BCYC
  • Stock Information
  • Founded
  • EVLV 2013
  • BCYC 2009
  • Country
  • EVLV United States
  • BCYC United Kingdom
  • Employees
  • EVLV N/A
  • BCYC N/A
  • Industry
  • EVLV Computer peripheral equipment
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVLV Technology
  • BCYC Health Care
  • Exchange
  • EVLV Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • EVLV 671.9M
  • BCYC 566.5M
  • IPO Year
  • EVLV N/A
  • BCYC 2019
  • Fundamental
  • Price
  • EVLV $6.64
  • BCYC $8.51
  • Analyst Decision
  • EVLV Buy
  • BCYC Buy
  • Analyst Count
  • EVLV 2
  • BCYC 11
  • Target Price
  • EVLV $6.50
  • BCYC $25.00
  • AVG Volume (30 Days)
  • EVLV 2.3M
  • BCYC 319.5K
  • Earning Date
  • EVLV 08-14-2025
  • BCYC 08-05-2025
  • Dividend Yield
  • EVLV N/A
  • BCYC N/A
  • EPS Growth
  • EVLV N/A
  • BCYC N/A
  • EPS
  • EVLV N/A
  • BCYC N/A
  • Revenue
  • EVLV $113,691,000.00
  • BCYC $25,722,000.00
  • Revenue This Year
  • EVLV $26.46
  • BCYC $7.35
  • Revenue Next Year
  • EVLV $18.80
  • BCYC N/A
  • P/E Ratio
  • EVLV N/A
  • BCYC N/A
  • Revenue Growth
  • EVLV 36.70
  • BCYC N/A
  • 52 Week Low
  • EVLV $2.04
  • BCYC $6.10
  • 52 Week High
  • EVLV $7.09
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • EVLV 64.06
  • BCYC 57.41
  • Support Level
  • EVLV $6.41
  • BCYC $8.40
  • Resistance Level
  • EVLV $7.09
  • BCYC $8.91
  • Average True Range (ATR)
  • EVLV 0.31
  • BCYC 0.46
  • MACD
  • EVLV 0.07
  • BCYC 0.07
  • Stochastic Oscillator
  • EVLV 71.70
  • BCYC 57.35

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: